|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.935 USD | +6.91% |
|
+1.06% | -0.16% |
| 05-14 | Serina Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-29 | Serina Therapeutics, Inc. announced that it has received $21.2 million in funding | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 2.1 | 3.54 | 2.87 |
| Spread/Res. | -9.05% | -46.05% | -33.45% |
| Spread/Supp. | +9.77% | +49.22% | +24.84% |
| Support | 1.74 | 1.28 | 1.53 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SER Stock
- Charts Serina Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
